Status:
COMPLETED
Ultrasonic Perfusion Estimation in Calf Muscle
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Peripheral Arterial Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to evaluate the potential of ultrasound perfusion imaging technique for assessing the progression of peripheral arterial disease (PAD) and monitoring its response to thera...
Detailed Description
The clinical manifestations of peripheral arterial disease (PAD), regardless of etiology, are due to a lack of blood flow to the musculature relative to its metabolism, which results in pain in the af...
Eligibility Criteria
Inclusion
- Male and female volunteers \> 18 years old.
- Male and female volunteers with symptom of claudication and suspected peripheral arterial disease (PAD) who are scheduled for vascular testing.
Exclusion
- Patients with gangrene.
- Patients with lower leg amputation.
- Having ulcer and any health condition that does not allow proper use of ultrasound scanning.
- People considered in "vulnerable" populations.
Key Trial Info
Start Date :
February 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 29 2023
Estimated Enrollment :
87 Patients enrolled
Trial Details
Trial ID
NCT04755335
Start Date
February 28 2020
End Date
May 29 2023
Last Update
April 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905